Spots Global Cancer Trial Database for Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
Official Title: Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
Study ID: NCT02151513
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.
Detailed Description: Biomarkers of immune function will be measured before and after patients receive an intrathecal pain pump for management of cancer pain.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Huntsman Cancer Hosptial, Salt Lake City, Utah, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
